Emergency Planning as Part of Healthcare Transition Preparation for Patients with Duchenne Muscular Dystrophy. Chouteau, WA; Burrows, C; Wittekind, SG; Rutter, MM; Bange, JE; Sabla, GE; Rybalsky, I; Tian, C. Journal of Pediatric Nursing. 2021; 61:298-304.

Age-related changes in appendicular lean mass in males with Duchenne muscular dystrophy: A retrospective review. Summer, SS; Wong, BL; Rutter, MM; Horn, PS; Tian, C; Rybalsky, I; Shellenbarger, KC; Kalkwarf, HJ. Muscle and Nerve. 2021; 63:231-238.

Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy. Nasomyont, N; Keefe, C; Tian, C; Hornung, L; Khoury, J; Tilden, JC; Hochwalt, P; Jackson, E; Rybalsky, I; Wong, BL; Rutter, MM. Osteoporosis International. 2020; 31:2449-2459.

Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy. Tian, C; Wong, BL; Hornung, L; Khoury, JC; Rybalsky, I; Shellenbarger, KC; Rutter, MM. Neuromuscular Disorders. 2020; 30:599-610.

Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy. Darmahkasih, AJ; Rybalsky, I; Tian, C; Shellenbarger, KC; Horn, PS; Lambert, JT; Wong, BL. Muscle and Nerve. 2020; 61:466-474.

MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy. Naarding, KJ; Reyngoudt, H; van Zwet, EW; Hooijmans, MT; Tian, C; Rybalsky, I; Shellenbarger, KC; Le Louer, J; Wong, BL; Carlier, PG; Kan, HE; Niks, EH. Neurology. 2020; 94:e1386-e1394.

Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy. Lambert, JT; Darmahkasih, AJ; Horn, PS; Rybalsky, I; Shellenbarger, KC; Tian, C; Wong, BL. Muscle and Nerve. 2020; 61:156-162.